Osteoporosis News and Research

Latest Osteoporosis News and Research

Hormone leptin could play a key role in treating bone loss, anorexia and infertility in women

A new study has found that the hormone leptin plays a key role in women’s reproductive and neuroendocrine health and suggests a future for the hormone in treating a number of conditions including exercise-induced bone loss, anorexia and in some cases of infertility.

2 Sep 2004

Are Latin America and the Caribbean ready to meet the health challenges of the coming senior boom?

Advances in medicine and public health have dramatically increased life expectancy in Latin America and the Caribbean.But is the region ready to meet the challenges of the coming "senior boom"?

31 Aug 2004

Ageing population and technological progress combine to drive European orthopaedic braces and supports market

By 2020, the elderly are expected to comprise almost a quarter of Europe's total population. This changing demography is set to underpin a rise in the incidence of age-related orthopaedic problems

31 Aug 2004

New guidelines today to diagnose and treat acromegaly

The American Association of Clinical Endocrinologists (AACE) released new guidelines today to diagnose and treat acromegaly, a rare and debilitating endocrine disorder. The guidelines are published in the May/June 2004 issue of AACE's peer-reviewed journal Endocrine Practice.

29 Aug 2004

Children who take steroid drugs for nephrotic syndrome do not suffer bone loss

Childhood nephrotic syndrome, which affects 3 out of 100,000 children, is the most common chronic kidney disease in children. Although it does not impair kidney function, it weakens the body's ability to remove water and salt from the blood, and causes swelling in the belly, legs, and around the eyes.

25 Aug 2004

Scientists have developed the first mouse model Werner’s syndrome

Scientists have developed the first mouse model of a rare disease in which people age rapidly and start developing cancers and other diseases associated with the elderly when they are only about 30 years old.

20 Aug 2004

Benefits from short-term hormone therapy are likely to outweigh the risks

A group of prominent experts on treatment of the menopause today issued advice for doctors on the use of hormone therapy.

13 Aug 2004

The largest North American breast cancer prevention trial ever undertaken has reached its goal of enrolling 19,000 women

The largest North American breast cancer prevention trial ever undertaken, the Study of Tamoxifen and Raloxifene (STAR), reached its goal of enrolling 19,000 women to the trial in June 2004, a month earlier than originally expected.

13 Aug 2004

Thyroid expert concerned about recently approved generic levothyroxine preparations

Levothyroxine is taken by more than 13 million Americans to treat an underactive thyroid, thyroid gland enlargement, nodules, or cancer. In June, the Food and Drug Administration (FDA) ruled that several generic levothyroxine preparations had the same clinical effect and safety profile as certain branded products.

11 Aug 2004

Link between short-term hormone therapy (HT) and improvements in life quality for women with menopausal symptoms

An article in the current issue of the Archives of Internal Medicine explains how a computer based simulation model has found a link between short-term hormone therapy (HT) and improvements in life quality for women with menopausal symptoms. The article also points out that short-term hormone therapy may actually shorten life expectancy.

10 Aug 2004

As the saying goes “breast milk is best”

As the saying goes “breast milk is best,” and more than 85 percent of new moms who give birth at the University of Michigan Health System agree and continue to breastfeed their new bundle of joy, on average, for the first six months.

3 Aug 2004

Half of women over 55 don't discuss osteoporosis with their doctors

A recent survey of 376 women age 55 and over found fewer than half of them discuss osteoporosis prevention therapies with their healthcare providers, yet this bone crippling disease is one of the major reasons women eventually lose their independence and enter nursing homes.

3 Aug 2004

Further evidence about how estrogen helps activate breast cancer

A UC Irvine researcher has found a novel tumor- suppressor function for a gene that, when mutated, often triggers breast cancer in women.

29 Jul 2004

Millions of American osteoporosis sufferers remain undiagnosed and untreated

Osteoporosis is a serious health condition that affects over 44 million Americans. The human and economic costs for this condition may account for some $17 billion in direct expenditures in hospitals and nursing homes and that annual expense is expected to triple by 2040.

26 Jul 2004

New DNA microarray to speed bone disease research

Velcura Therapeutics has announced the development of a custom Affymetrix GeneChip(R) array that aids the development of bone disease therapies by enabling researchers to follow global changes in gene expression during human bone formation.

23 Jul 2004

First strokes now bone health, moderate alcohol consumption good for women

Moderate drinking seems to keep brittle bones at bay in women, a new study of identical twins suggests.

1 Jul 2004

New educational campaign on celiac disease

The Children's Digestive Health and Nutrition Foundation (CDHNF) with the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) today announced the launch of a new educational campaign on celiac disease

30 Jun 2004

New Harvard website recommendations could help prevent over half of all chronic disease in the U.S.

Your Disease Risk offers users the chance to find out their risk of five of the most important diseases in the United States and get personalized tips for preventing them.

29 Jun 2004

Hormone replacement therapy in women increases risk of dementia

These "surprising and significant findings" are reported in two studies from the Women's Health Initiative Memory Study, in which UC Medical Center participates, in today's issue of the Journal of the American Medical Association (JAMA).

28 Jun 2004

50,000 people in the U.S. with cancer, multiple sclerosis, rheumatoid arthritis or hepatitis C will be eligible for a Medicare drug lottery

50,000 people or 10% of the 500,000 people in the U.S with cancer, multiple sclerosis, rheumatoid arthritis or hepatitis C will be eligible for a Medicare drug lottery for coverage of life saving drugs.

26 Jun 2004

Osteoporosis News and Research

Latest Osteoporosis News and Research

Hormone leptin could play a key role in treating bone loss, anorexia and infertility in women

Are Latin America and the Caribbean ready to meet the health challenges of the coming senior boom?

Ageing population and technological progress combine to drive European orthopaedic braces and supports market

New guidelines today to diagnose and treat acromegaly

Children who take steroid drugs for nephrotic syndrome do not suffer bone loss

Scientists have developed the first mouse model Werner’s syndrome

Benefits from short-term hormone therapy are likely to outweigh the risks

The largest North American breast cancer prevention trial ever undertaken has reached its goal of enrolling 19,000 women

Thyroid expert concerned about recently approved generic levothyroxine preparations

Link between short-term hormone therapy (HT) and improvements in life quality for women with menopausal symptoms

As the saying goes “breast milk is best”

Half of women over 55 don't discuss osteoporosis with their doctors

Further evidence about how estrogen helps activate breast cancer

Millions of American osteoporosis sufferers remain undiagnosed and untreated

New DNA microarray to speed bone disease research

First strokes now bone health, moderate alcohol consumption good for women

New educational campaign on celiac disease

New Harvard website recommendations could help prevent over half of all chronic disease in the U.S.

Hormone replacement therapy in women increases risk of dementia

50,000 people in the U.S. with cancer, multiple sclerosis, rheumatoid arthritis or hepatitis C will be eligible for a Medicare drug lottery

Innovation in neuroscience drug discovery - eBook eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Osteoporosis News and Research

Latest Osteoporosis News and Research

Innovation in neuroscience drug discovery - eBook eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in